Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review

There has long been a recognised association between non-alcoholic fatty liver disease (NAFLD) and the composite aspects of the metabolic syndrome. Part of this association highlighted the supposed co-existence of elevated uric acid levels in those with NAFLD. There is interest in exploitation of th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2020-04, Vol.26 (15), p.1683-1690
Hauptverfasser: Brennan, Paul, Clare, Kathleen, George, Jacob, Dillon, John F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1690
container_issue 15
container_start_page 1683
container_title World journal of gastroenterology : WJG
container_volume 26
creator Brennan, Paul
Clare, Kathleen
George, Jacob
Dillon, John F
description There has long been a recognised association between non-alcoholic fatty liver disease (NAFLD) and the composite aspects of the metabolic syndrome. Part of this association highlighted the supposed co-existence of elevated uric acid levels in those with NAFLD. There is interest in exploitation of this as a putative diagnostic and prognostic biomarker in NAFLD. Given the increased economic and health burden associated with the NAFLD epidemic, improved methods of population-based, minimally-invasive methods and biomarkers are clearly highly sought and necessary. In this opinion review we review the proposed role of uric acid in the pathogenesis of NAFLD and its potential utilisation in the diagnosis and monitoring of the disease process.
doi_str_mv 10.3748/wjg.v26.i15.1683
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7183862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2396854744</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-1ab0f2c727561015af15927f02f468dc9c71d8cefb39d3857cba3f7066b60a193</originalsourceid><addsrcrecordid>eNpVkc1u1DAUhS0EokNhzwp5ySaDfxLbYYFUlb9Kldi0a8txrmdcJXawnan6Hn1gPLRUdGXp-p7vHulD6D0lWy5b9en2Zrc9MLH1tNtSofgLtGGM9g1TLXmJNpQQ2fScyRP0JucbQhjnHXuNTjjjHWVKbND9VyiQZh982OGyB5ziBNjFhNfkLTbWj9gHHGJozGTjPk51mguYEvewmOKLz3iEA0xxmSEUbML4l7MWP_lyh6OrJFMAz1DMUOMF8pE4erMLMfv8GZ8FHJfaIAac4ODh9i165cyU4d3je4quv3-7Ov_ZXP76cXF-dtlY3ovSUDMQx6xkshOU0M442vVMOsJcK9RoeyvpqCy4gfcjV520g-FOEiEGQQzt-Sn68sBd1mGG0db-yUx6SX426U5H4_Xzn-D3ehcPWlLFlWAV8PERkOLvFXLRs88WpskEiGvWrPZUXSvbtq6Sh1WbYs4J3NMZSvRRpq4ydZWpq0x9lFkjH_6v9xT4Z4__AQ4joL4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2396854744</pqid></control><display><type>article</type><title>Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Brennan, Paul ; Clare, Kathleen ; George, Jacob ; Dillon, John F</creator><creatorcontrib>Brennan, Paul ; Clare, Kathleen ; George, Jacob ; Dillon, John F</creatorcontrib><description>There has long been a recognised association between non-alcoholic fatty liver disease (NAFLD) and the composite aspects of the metabolic syndrome. Part of this association highlighted the supposed co-existence of elevated uric acid levels in those with NAFLD. There is interest in exploitation of this as a putative diagnostic and prognostic biomarker in NAFLD. Given the increased economic and health burden associated with the NAFLD epidemic, improved methods of population-based, minimally-invasive methods and biomarkers are clearly highly sought and necessary. In this opinion review we review the proposed role of uric acid in the pathogenesis of NAFLD and its potential utilisation in the diagnosis and monitoring of the disease process.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v26.i15.1683</identifier><identifier>PMID: 32351286</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Biomarkers - blood ; Biomarkers - metabolism ; Humans ; Hyperuricemia - blood ; Hyperuricemia - complications ; Hyperuricemia - diagnosis ; Liver - metabolism ; Liver - pathology ; Non-alcoholic Fatty Liver Disease - blood ; Non-alcoholic Fatty Liver Disease - diagnosis ; Non-alcoholic Fatty Liver Disease - etiology ; Non-alcoholic Fatty Liver Disease - metabolism ; Opinion Review ; Uric Acid - blood ; Uric Acid - metabolism</subject><ispartof>World journal of gastroenterology : WJG, 2020-04, Vol.26 (15), p.1683-1690</ispartof><rights>The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><rights>The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-1ab0f2c727561015af15927f02f468dc9c71d8cefb39d3857cba3f7066b60a193</citedby><cites>FETCH-LOGICAL-c396t-1ab0f2c727561015af15927f02f468dc9c71d8cefb39d3857cba3f7066b60a193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183862/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183862/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32351286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brennan, Paul</creatorcontrib><creatorcontrib>Clare, Kathleen</creatorcontrib><creatorcontrib>George, Jacob</creatorcontrib><creatorcontrib>Dillon, John F</creatorcontrib><title>Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>There has long been a recognised association between non-alcoholic fatty liver disease (NAFLD) and the composite aspects of the metabolic syndrome. Part of this association highlighted the supposed co-existence of elevated uric acid levels in those with NAFLD. There is interest in exploitation of this as a putative diagnostic and prognostic biomarker in NAFLD. Given the increased economic and health burden associated with the NAFLD epidemic, improved methods of population-based, minimally-invasive methods and biomarkers are clearly highly sought and necessary. In this opinion review we review the proposed role of uric acid in the pathogenesis of NAFLD and its potential utilisation in the diagnosis and monitoring of the disease process.</description><subject>Biomarkers - blood</subject><subject>Biomarkers - metabolism</subject><subject>Humans</subject><subject>Hyperuricemia - blood</subject><subject>Hyperuricemia - complications</subject><subject>Hyperuricemia - diagnosis</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Non-alcoholic Fatty Liver Disease - blood</subject><subject>Non-alcoholic Fatty Liver Disease - diagnosis</subject><subject>Non-alcoholic Fatty Liver Disease - etiology</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Opinion Review</subject><subject>Uric Acid - blood</subject><subject>Uric Acid - metabolism</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc1u1DAUhS0EokNhzwp5ySaDfxLbYYFUlb9Kldi0a8txrmdcJXawnan6Hn1gPLRUdGXp-p7vHulD6D0lWy5b9en2Zrc9MLH1tNtSofgLtGGM9g1TLXmJNpQQ2fScyRP0JucbQhjnHXuNTjjjHWVKbND9VyiQZh982OGyB5ziBNjFhNfkLTbWj9gHHGJozGTjPk51mguYEvewmOKLz3iEA0xxmSEUbML4l7MWP_lyh6OrJFMAz1DMUOMF8pE4erMLMfv8GZ8FHJfaIAac4ODh9i165cyU4d3je4quv3-7Ov_ZXP76cXF-dtlY3ovSUDMQx6xkshOU0M442vVMOsJcK9RoeyvpqCy4gfcjV520g-FOEiEGQQzt-Sn68sBd1mGG0db-yUx6SX426U5H4_Xzn-D3ehcPWlLFlWAV8PERkOLvFXLRs88WpskEiGvWrPZUXSvbtq6Sh1WbYs4J3NMZSvRRpq4ydZWpq0x9lFkjH_6v9xT4Z4__AQ4joL4</recordid><startdate>20200421</startdate><enddate>20200421</enddate><creator>Brennan, Paul</creator><creator>Clare, Kathleen</creator><creator>George, Jacob</creator><creator>Dillon, John F</creator><general>Baishideng Publishing Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200421</creationdate><title>Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review</title><author>Brennan, Paul ; Clare, Kathleen ; George, Jacob ; Dillon, John F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-1ab0f2c727561015af15927f02f468dc9c71d8cefb39d3857cba3f7066b60a193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biomarkers - blood</topic><topic>Biomarkers - metabolism</topic><topic>Humans</topic><topic>Hyperuricemia - blood</topic><topic>Hyperuricemia - complications</topic><topic>Hyperuricemia - diagnosis</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Non-alcoholic Fatty Liver Disease - blood</topic><topic>Non-alcoholic Fatty Liver Disease - diagnosis</topic><topic>Non-alcoholic Fatty Liver Disease - etiology</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Opinion Review</topic><topic>Uric Acid - blood</topic><topic>Uric Acid - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Brennan, Paul</creatorcontrib><creatorcontrib>Clare, Kathleen</creatorcontrib><creatorcontrib>George, Jacob</creatorcontrib><creatorcontrib>Dillon, John F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brennan, Paul</au><au>Clare, Kathleen</au><au>George, Jacob</au><au>Dillon, John F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2020-04-21</date><risdate>2020</risdate><volume>26</volume><issue>15</issue><spage>1683</spage><epage>1690</epage><pages>1683-1690</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>There has long been a recognised association between non-alcoholic fatty liver disease (NAFLD) and the composite aspects of the metabolic syndrome. Part of this association highlighted the supposed co-existence of elevated uric acid levels in those with NAFLD. There is interest in exploitation of this as a putative diagnostic and prognostic biomarker in NAFLD. Given the increased economic and health burden associated with the NAFLD epidemic, improved methods of population-based, minimally-invasive methods and biomarkers are clearly highly sought and necessary. In this opinion review we review the proposed role of uric acid in the pathogenesis of NAFLD and its potential utilisation in the diagnosis and monitoring of the disease process.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>32351286</pmid><doi>10.3748/wjg.v26.i15.1683</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2020-04, Vol.26 (15), p.1683-1690
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7183862
source MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Biomarkers - blood
Biomarkers - metabolism
Humans
Hyperuricemia - blood
Hyperuricemia - complications
Hyperuricemia - diagnosis
Liver - metabolism
Liver - pathology
Non-alcoholic Fatty Liver Disease - blood
Non-alcoholic Fatty Liver Disease - diagnosis
Non-alcoholic Fatty Liver Disease - etiology
Non-alcoholic Fatty Liver Disease - metabolism
Opinion Review
Uric Acid - blood
Uric Acid - metabolism
title Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A29%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determining%20the%20role%20for%20uric%20acid%20in%20non-alcoholic%20steatohepatitis%20development%20and%20the%20utility%20of%20urate%20metabolites%20in%20diagnosis:%20An%20opinion%20review&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Brennan,%20Paul&rft.date=2020-04-21&rft.volume=26&rft.issue=15&rft.spage=1683&rft.epage=1690&rft.pages=1683-1690&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v26.i15.1683&rft_dat=%3Cproquest_pubme%3E2396854744%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2396854744&rft_id=info:pmid/32351286&rfr_iscdi=true